Evidence map›Paper›PMID 42147803›Full record

ArticleCase reports in immunology2026

Homozygous C1qA Deficiency Presenting as Early-Onset Systemic Lupus Erythematosus: A Case Report With a Literature Review.

Hadi Mottaghipisheh, Andisheh Mosaffa Jahromi, Fatemeh Mirzaei, Seppo Meri, Kurosh Kalantar

Abstract read
In one paragraph

Article in Case reports in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hadi MottaghipishehHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
Andisheh Mosaffa JahromiDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
Fatemeh MirzaeiDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.
Seppo MeriDepartment of Bacteriology and Immunology, Translational Immunology Research Program (TRIMM), University of Helsinki and HUSLAB, Helsinki University Hospital, Helsinki, Finland, hus.fi.ORCID https://orcid.org/0000-0001-9142-501X
Kurosh KalantarDepartment of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, sums.ac.ir.ORCID https://orcid.org/0000-0002-9160-9449

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Childhood-onset systemic lupus erythematosus (cSLE) can be particularly severe when associated with inborn errors of immunity. Hereditary C1q deficiency is an exceptionally rare complement disorder that confers a very high risk of early, aggressive lupus. Reporting this case highlights the need to consider complement deficiencies in young children presenting with lupus-like features and recurrent infections and illustrates the diagnostic value of integrating immunologic and genetic testing. Case Presentation: A 3-year-old girl presented with recurrent infections, a photosensitive rash, and persistent leukopenia, raising clinical suspicion for an underlying complement deficiency in the context of cSLE. Laboratory evaluation showed strongly positive antinuclear antibody (ANA) and anti-SSA antibodies, with normal C3 and C4 levels but markedly reduced CH50. Lymphocyte subset analysis by flow cytometry was unremarkable. Western blot analysis and whole-exome sequencing identified a homozygous nonsense variant in C1qA (c.622C > Conclusions: This case emphasizes the importance of early recognition and systematic evaluation of complement deficiencies in pediatric patients with lupus manifestations and recurrent infections. Identifying hereditary C1q deficiency has crucial implications for diagnosis, prognosis, and timely selection of advanced therapies, including hematopoietic stem cell transplantation, in severe forms of cSLE.

Indexed as

autoimmunityC1qAcomplementsystemic lupus erythematosus (SLE)

Identifiers

PMID42147803
PMCPMC13173544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.